DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Accretion Pharmaceuticals Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 3 hrs ago·6 Oct 2026, 11:56 am

Accretion Pharma

Accretion Pharmaceuticals Ltd submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018 to the stock exchange. This filing confirms that the company has complied with the rules governing depository participants, such as maintaining proper records of dematerialised securities and ensuring its shares are held in electronic form.

For investors, the filing is a routine compliance update and does not signal any immediate change in the company's operations or financials. It reassures that the shares of ACCPL are being managed in line with regulatory standards, which helps maintain market integrity and reduces the risk of settlement issues.

Investors should watch for any subsequent disclosures from the company, especially updates on shareholding patterns, corporate actions, or further regulatory filings that could affect the stock.